Palla Pharma (PAL) Stock Price, News & Analysis

Company Overview

Palla Pharma Limited, a vertically integrated pharmaceutical company, produces and distributes narcotic raw materials, active pharmaceutical ingredients, and finished dosage formulations for pharmaceutical markets in Australia and Norway. It also produces and distributes poppy seeds to culinary markets. The company was formerly known as TPI Enterprises Limited and changed its name to Palla Pharma Limited in June 2019. Palla Pharma Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Consumer Defensive
• Industry: Farm Products
• Sub-Industry: Transportation
• Current Symbol: ASX:PAL
• CIK: N/A
• Web: www.pallapharma.com
• Phone: 61 3 9301 0800
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 77.50
• Current Ratio: 1.09
• Quick Ratio: 0.16

Sales & Book Value

• Annual Sales: A$16.74 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.12 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 161,912,992
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A